General Information of the Compound
Compound ID
CP0098913
Compound Name
(S)-3,4-dichloro-N-(1-(4-(3-(dimethylamino)propoxy)benzyl)pyrrolidin-3-yl)benzamide
    Show/Hide
Synonyms
(S)-3,4-dichloro-N-(1-(4-(3-(dimethylamino)propoxy)benzyl)pyrrolidin-3-yl)benzamide
(S)-N-(1-(4-(3-(dimethylamino)propoxy)benzyl)pyrrolidin-3-yl)-3,4-dichlorobenzamide
3,4-Dichloro-N-{(S)-1-[4-(3-dimethylamino-propoxy)-benzyl]-pyrrolidin-3-yl}-benzamide
346729-66-6
BDBM50240963
Benzamide,3,4-dichloro-N-[(3S)-1-[[4-[3-(dimethylamino)propoxy]phenyl]methyl]-3-pyrrolidinyl]-
CHEMBL366221
GTPL2164
KB-74923
SB-436811
SCHEMBL6949936
ZINC3964101
    Show/Hide
Structure
Formula
C23H29Cl2N3O2
Molecular Weight
450.41
Canonical SMILES
CN(C)CCCOc1ccc(CN2CC[C@@H](C2)NC(=O)c2ccc(Cl)c(Cl)c2)cc1
    Show/Hide
InChI
InChI=1S/C23H29Cl2N3O2/c1-27(2)11-3-13-30-20-7-4-17(5-8-20)15-28-12-10-19(16-28)26-23(29)18-6-9-21(24)22(25)14-18/h4-9,14,19H,3,10-13,15-16H2,1-2H3,(H,26,29)/t19-/m0/s1
    Show/Hide
InChIKey
AMSSIFVGNFEEFU-IBGZPJMESA-N
Physicochemical Property
logP
4.3282
Rotatable Bonds
9
Heavy Atom Count
30
Polar Areas
44.81
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9846574
SID: 16619988
ChEMBL ID
CHEMBL366221
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02463, Urotensin-2 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  4
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS
2
IC50 = 170 nM
   TI
   LI
   LO
   TS
3
Ki = 199.53 nM
   TI
   LI
   LO
   TS
4
Ki = 200 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 200 nM
Clinical Information about the Compound
Drug 1 ( SB-436811 )
Drug Name SB-436811
Indication
Asthma
Phase 1
Target(s)
Urotensin II receptor (UTS2R)
Inhibitor